|
OCCASIONAL ESSAYS
On Primo Levi and the art of science writing
On pH and why it's good to score 7.4
Vampires and porphyria
The Observer - Review of Creation by Adam Rutherford
FEATURES FOR EUROTIMES (European Society for Cataract and Refractive Surgery)
1. Lane N. Darwin
and the evolution of the eye. EuroTimes (ESCRS) June 2009.
2. Lane N. MRSA: The rising menace. EuroTimes
(ESCRS) October 2008.
3. Lane N. Who is
paying the piper? Open access journals. EuroTimes (ESCRS) January 2008.
4. Lane N. Beyond the IOL. EuroTimes
(ESCRS) September 2007.
5. Lane N. To block or not
to block: Is blue light the enemy? EuroTimes (ESCRS) July 2007.
6. Lane N. Cannabis and
glaucoma - the inside story. EuroTimes (ESCRS) April 2007.
7. Lane N. The great
accomodation debate. EuroTimes (ESCRS) January 2007.
8. Lane N. Mitochondria –
alpha and omega of retinal disease? EuroTimes (ESCRS) September 2006.
9. Lane N. Pioneers
past and present; but where are the boundaries of the justifiable? EuroTimes
(ESCRS) January 2006.
10. Lane N. New VEGF
antagonists in AMD: new quandaries abound. EuroTimes (ESCRS) November
2005.
11. Lane N. Stem cells in ophthalmology:
dawn of a new era? EuroTimes (ESCRS) October 2005.
12. Lane N. Ophthalmic gene
testing: ready for prime time? EuroTimes (ESCRS) August 2005.
13. Lane
N. Conflict of interest crisis: researchers and regulators at odds over
reform proposals. EuroTimes (ESCRS) June 2005.
14. Lane N. Evidence-based
medicine – never better than the evidence itself. EuroTimes (ESCRS)
June 2004.
15. Lane N. Rheopheresis: ready
for prime time? EuroTimes (ESCRS) November 2004.
16. Lane N. Vision 2020: Eliminating preventable blindness in the developing
world? EuroTimes (ESCRS) February 2004.
17. Lane N. EMEA on the brink of the new EU. EuroTimes (ESCRS) November
2003.
18.
Lane N. Antioxidants: who do you believe? EuroTimes (ESCRS) October 2003.
19. Lane N. Verteporfin’s efficacy in AMD comes into focus. EuroTimes
(ESCRS) August 2003.
|